China Health Group Inc., together with its subsidiaries, researches and develops bio, natural, and synthetic drugs in the People's Republic of China. It engages in the pharmacodynamics and clinical research of drugs; provision of post market and contracted pharmaceutical development services; and technological transfer and services for the research and development of drugs. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in February 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, China.
Frequently asked questions
What sector does China Health Group Inc (8225) operate in?
China Health Group Inc belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is China Health Group Inc (8225) current stock price?
As of the latest data, China Health Group Inc stock price is HK$0.07, with a previous close of HK$0.07.
What is China Health Group Inc (8225) current market capitalization?
China Health Group Inc market cap is approximately 68.68 million.
What is China Health Group Inc (8225) EBITDA?
China Health Group Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 11.01 million.
Does China Health Group Inc (8225) pay dividends?
No. China Health Group Inc does not pay a dividend.
What is China Health Group Inc (8225) beta (volatility) score?
China Health Group Inc has a beta of -0.310, indicating lower volatility than the overall market.